Related Experiment Video
Updated: Aug 12, 2026
17:42
A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
Published on: April 13, 2011
Islet transplantation: present and future perspectives
N S Kenyon1, A Ranuncoli, M Masetti
1Diabetes Research Institute, University of Miami School of Medicine, FL 33136, USA.
Diabetes/Metabolism Reviews
|March 30, 1999
Summary
Islet cell transplantation shows promise for managing Type 1 diabetes by normalizing blood glucose. However, challenges like engraftment, rejection, and immunosuppression side effects must be overcome for wider application.
Area of Science:
- Endocrinology
- Transplantation Immunology
Background:
- Islet cell transplantation offers potential for normalizing blood glucose and preventing complications in Type 1 diabetes.
- Recent advancements have shown success in metabolic control, but insulin independence remains elusive for most patients.
Purpose of the Study:
- To review the current state of islet cell transplantation for Type 1 diabetes.
- To identify key challenges hindering broader clinical application and discuss future research directions.
Main Methods:
- Review of recent scientific literature on islet cell transplantation.
- Analysis of outcomes, complications, and unresolved issues in Type 1 diabetes treatment.
Main Results:
- Successful normalization of metabolic control achieved in some patients without hypoglycemia.
- Limited success in achieving long-term insulin independence.
- Significant challenges persist regarding islet engraftment, immune rejection, and recurrent autoimmunity.
Conclusions:
- Islet cell transplantation holds significant therapeutic potential for Type 1 diabetes.
- Overcoming challenges in engraftment, immunosuppression, and immune tolerance is crucial for expanding patient eligibility.
- Development of targeted immunointervention strategies is needed to make this procedure suitable for all patients.
